The presence of brisk tumor-infiltrating CD8+ lymphocytes was significantly higher in GO patients than in BO patients (median positivity of 6.1% vs. 1.65%, range 0-34.5% vs. 0-6.3%), p=0.004), as previously reported (23). The gene discussed is CD8A; the disease is neoplasm.